Yahoo Web Search

Search results

    • Risky but high-reward stock to buy

      • Overall, given the vast institutional interest, its stable financial position, and the success of similar gene therapeutics in the industry, Editas is a risky but high-reward stock to buy.
      www.fool.com › investing › 2021/01/26
  1. 2 days ago · Should You Buy or Sell Editas Medicine Stock? Get The Latest EDIT Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

    • (617) 401-9000
    • 11 Hurley Street, Cambridge MA, 02141
    • mark.mullikin@editasmed.com
  2. People also ask

  3. Jan 26, 2021 · Overall, given the vast institutional interest, its stable financial position, and the success of similar gene therapeutics in the industry, Editas is a risky but high-reward stock to buy.

  4. 6 days ago · Should I buy Editas Medicine (EDIT)? Use the Zacks Rank and Style Scores to find out is EDIT is right for your portfolio.

  5. May 30, 2024 · Analysts have set 12-month price targets for Editas Medicine, revealing an average target of $9.5, a high estimate of $15.00, and a low estimate of $7.00. Highlighting a 32.14% decrease, the ...

  6. Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing.

  7. 5 days ago · Get a real-time Editas Medicine, Inc. (EDIT) stock price quote with breaking news, financials, statistics, charts and more.

  8. Feb 6, 2024 · Editas Medicine (EDIT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates...

  1. People also search for